The Food and Drug Administration has approved a new drug to treat advanced pancreatic cancer. This breakthrough drug is intended for individuals with metastatic pancreatic cancer. The approval was announced on Wednesday and could potentially extend the survival of those affected by this condition.

Further details about the drug and its approval are available from the source, providing more information on this development and its potential impact on treatment for metastatic pancreatic cancer.